By Sneha S K and Bageshri Banerjee (Reuters) -The U.S. Food and Drug Administration on Thursday approved Ionis ...

A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...

The Food and Drug Administration has authorized emergency use of animal drugs to treat and prevent infestations of the New ...

A little boy in the Chicago area is battling a rare disease and desperately needs a drug treatment for a better life. The ...

The initiative is a response to a Trump administration order to speed the construction of the type of new drug factories many ...

The FDA said it has begun publishing reports of adverse events concerning drugs on a daily basis, instead of quarterly, as it ...

The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' oral medication for a rare genetic disorder ...

The Food and Drug Administration (FDA) became authorized Tuesday to allow the use of animal drugs to treat or prevent ...

Dawnzera is the third medicine cleared by U.S. regulators this year for the rare genetic condition, and the second wholly owned medicine Ionis has brought to market.

Ionis Pharmaceuticals won FDA approval for a drug that prevents painful swelling attacks triggered by a rare genetic ...

An herbal supplement that’s marketed as a cure-all for chronic pain and sold in gas stations and smoke shops is getting ...